At difference with other CLL cases tested, the amount of RANKL released by purified CD19+ leukemic B cells was already detectable in basal conditions (102 pg/mL) and aberrantly increased after CPG activation (1600 pg/mL). The gene discussed is TNFSF11; the disease is B-cell chronic lymphocytic leukemia.